Study #2018-1172
Feasibility of Dietary Magnesium Replacement for Prevention of Hypomagnesemia In Ovarian Cancer Patients Receiving Carboplatin Chemotherapy
MD Anderson Study Status
Not Accepting
Treatment Agent
Dietary Supplement: Dietary Intervention
Description
This trial studies how well a diet high in magnesium works in preventing low blood magnesium levels (hypomagnesemia) in patients with ovarian cancer receiving carboplatin chemotherapy. Hypomagnesemia is a common side effect of carboplatin-containing chemotherapy. A magnesium rich diet may increase the levels of magnesium in the blood and help prevent hypomagnesemia resulting from carboplatin chemotherapy.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Ovarian Carcinoma
Study phase:
Not applicable
Physician name:
Lorenzo Cohen
Department:
Palliative Care & Rehabilitation Medicine
For general questions about clinical trials:
1-844-866-3603
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.